Literature DB >> 20808239

An ultrasound contrast agent targeted to P-selectin detects activated platelets at supra-arterial shear flow conditions.

Felix Guenther1, Constantin von zur Muhlen, Elisa A Ferrante, Sebastian Grundmann, Christoph Bode, Alexander L Klibanov.   

Abstract

OBJECTIVES: To evaluate targeting of a microbubble contrast agent to platelets under high shear flow using the natural selectin ligand sialyl Lewis.
MATERIALS AND METHODS: Biotinylated polyacrylamide Sialyl Lewis or biotinylated carbohydrate-free polymer (used as a control) were attached to biotinylated microbubbles via a streptavidin linker. Activated human platelets were isolated and attached to fibrinogen-coated culture dishes. Fibrinogen-coated dishes without platelets or platelet dishes blocked by an anti-P-selectin antibody served as negative control substrates. Dishes coated by recombinant P-selectin served as a positive control substrate. Microbubble adhesion was assessed by microscopy in an inverted parallel plate flow chamber, with wall shear stress values of 40, 30, 20, 10, and 5 dynes/cm2. The ratio of binding and passing microbubbles was defined as capture efficiency.
RESULTS: There was no significant difference between the groups regarding the number of microbubbles in the fluid flow at each shear rate. Sialyl Lewis-targeted microbubbles were binding and slowly rolling on the surface of activated platelets and P-selectin-coated dishes at all the flow conditions including 40 dynes/cm2. Capture efficiency of targeted microbubbles to activated platelets and recombinant P-selectin decreased with increasing shear flow: at 5 dynes/cm2, capture efficiency was 16.11% on activated platelets versus 21.83% on P-selectin, and, at 40 dynes/cm2, adhesion efficiency was still 3.4% in both groups. There was neither significant adhesion of Sialyl Lewis-targeted microbubbles to control substrates, nor adhesion of control microbubbles to activated platelets or to recombinant P-selectin.
CONCLUSIONS: Microbubble targeting using sialyl Lewis, a fast-binding ligand to P-selectin, is a promising strategy for the design of ultrasound contrast binding to activated platelets under high shear stress conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20808239      PMCID: PMC3426507          DOI: 10.1097/RLI.0b013e3181ed1b3b

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  51 in total

1.  Cell-free rolling mediated by L-selectin and sialyl Lewis(x) reveals the shear threshold effect.

Authors:  A W Greenberg; D K Brunk; D A Hammer
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

2.  Selectin ligands promote ultrasound contrast agent adhesion under shear flow.

Authors:  J J Rychak; B Li; S T Acton; A Leppänen; R D Cummings; K Ley; A L Klibanov
Journal:  Mol Pharm       Date:  2006 Sep-Oct       Impact factor: 4.939

3.  Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound.

Authors:  Angelika Alonso; Alberto Della Martina; Mark Stroick; Marc Fatar; Martin Griebe; Sibylle Pochon; Michel Schneider; Michael Hennerici; Eric Allémann; Stephen Meairs
Journal:  Stroke       Date:  2007-03-22       Impact factor: 7.914

4.  Enhanced detection of thromboemboli with the use of targeted microbubbles.

Authors:  Matthew J Martin; Emma M L Chung; Alison H Goodall; Alberto Della Martina; Kumar V Ramnarine; Lingke Fan; Sarah V Hainsworth; A Ross Naylor; David H Evans
Journal:  Stroke       Date:  2007-09-06       Impact factor: 7.914

Review 5.  Radionuclide imaging: a molecular key to the atherosclerotic plaque.

Authors:  Harald F Langer; Roland Haubner; Bernd J Pichler; Meinrad Gawaz
Journal:  J Am Coll Cardiol       Date:  2008-07-01       Impact factor: 24.094

6.  Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis.

Authors:  C von zur Muhlen; D von Elverfeldt; J A Moeller; R P Choudhury; D Paul; C E Hagemeyer; M Olschewski; A Becker; I Neudorfer; N Bassler; M Schwarz; C Bode; K Peter
Journal:  Circulation       Date:  2008-06-23       Impact factor: 29.690

Review 7.  Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging.

Authors:  Claire Corot; Klaus G Petry; Rikin Trivedi; Andreas Saleh; Cornelia Jonkmanns; Jean-François Le Bas; Erwin Blezer; Martin Rausch; Bruno Brochet; Paula Foster-Gareau; Danièle Balériaux; Sophile Gaillard; Vincent Dousset
Journal:  Invest Radiol       Date:  2004-10       Impact factor: 6.016

8.  Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.

Authors:  Carmen Burtea; Sophie Laurent; Oltea Murariu; Dirk Rattat; Gérard Toubeau; Alfons Verbruggen; David Vansthertem; Luce Vander Elst; Robert N Muller
Journal:  Cardiovasc Res       Date:  2008-01-03       Impact factor: 10.787

Review 9.  High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis.

Authors:  Torjus Skajaa; David P Cormode; Erling Falk; Willem J M Mulder; Edward A Fisher; Zahi A Fayad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-08       Impact factor: 8.311

10.  Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.

Authors:  Josef Vymazal; Elmar Spuentrup; Gerardo Cardenas-Molina; Andrea J Wiethoff; Michael G Hartmann; Peter Caravan; Edward C Parsons
Journal:  Invest Radiol       Date:  2009-11       Impact factor: 6.016

View more
  12 in total

Review 1.  Leveraging the power of ultrasound for therapeutic design and optimization.

Authors:  Charles F Caskey; Xiaowen Hu; Katherine W Ferrara
Journal:  J Control Release       Date:  2011-07-30       Impact factor: 9.776

Review 2.  Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.

Authors:  Natalya Rapoport
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-06-22

Review 3.  Phase-shift, stimuli-responsive drug carriers for targeted delivery.

Authors:  Brian E O'Neill; Natalya Rapoport
Journal:  Ther Deliv       Date:  2011-09

Review 4.  Targeting of microbubbles: contrast agents for ultrasound molecular imaging.

Authors:  Shiying Wang; John A Hossack; Alexander L Klibanov
Journal:  J Drug Target       Date:  2018-01-09       Impact factor: 5.121

5.  Insonation of targeted microbubbles produces regions of reduced blood flow within tumor vasculature.

Authors:  Xiaowen Hu; Azadeh Kheirolomoom; Lisa M Mahakian; Julie R Beegle; Dustin E Kruse; Kit S Lam; Katherine W Ferrara
Journal:  Invest Radiol       Date:  2012-07       Impact factor: 6.016

Review 6.  Ultrasound in Radiology: From Anatomic, Functional, Molecular Imaging to Drug Delivery and Image-Guided Therapy.

Authors:  Alexander L Klibanov; John A Hossack
Journal:  Invest Radiol       Date:  2015-09       Impact factor: 6.016

7.  Shear forces from flow are responsible for a distinct statistical signature of adherent microbubbles in large vessels.

Authors:  Shiying Wang; F William Mauldin; Alexander L Klibanov; John A Hossack
Journal:  Mol Imaging       Date:  2013-09       Impact factor: 4.488

Review 8.  Ultrasound contrast materials in cardiovascular medicine: from perfusion assessment to molecular imaging.

Authors:  Alexander L Klibanov
Journal:  J Cardiovasc Transl Res       Date:  2013-08-03       Impact factor: 4.132

Review 9.  Novel delivery approaches for cancer therapeutics.

Authors:  Ashim K Mitra; Vibhuti Agrahari; Abhirup Mandal; Kishore Cholkar; Chandramouli Natarajan; Sujay Shah; Mary Joseph; Hoang M Trinh; Ravi Vaishya; Xiaoyan Yang; Yi Hao; Varun Khurana; Dhananjay Pal
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

10.  Contrast-enhanced ultrasound molecular imaging of activated platelets in the progression of atherosclerosis using microbubbles bearing the von Willebrand factor A1 domain.

Authors:  Jie Tian; Yahui Weng; Ruiying Sun; Ying Zhu; Jun Zhang; Hongyun Liu; Yani Liu
Journal:  Exp Ther Med       Date:  2021-05-03       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.